155 related articles for article (PubMed ID: 28504304)
1. Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.
Vasquez M; Simões I; Consuegra-Fernández M; Aranda F; Lozano F; Berraondo P
Eur J Immunol; 2017 Jul; 47(7):1108-1118. PubMed ID: 28504304
[TBL] [Abstract][Full Text] [Related]
2. The ectodomains of the lymphocyte scavenger receptors CD5 and CD6 interact with tegumental antigens from Echinococcus granulosus sensu lato and protect mice against secondary cystic echinococcosis.
Mourglia-Ettlin G; Miles S; Velasco-De-Andrés M; Armiger-Borràs N; Cucher M; Dematteis S; Lozano F
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006891. PubMed ID: 30500820
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.
Velasco-de Andrés M; Casadó-Llombart S; Català C; Leyton-Pereira A; Lozano F; Aranda F
Cells; 2020 Dec; 9(12):. PubMed ID: 33287301
[TBL] [Abstract][Full Text] [Related]
4. Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B cells.
Zhu P; Liu X; Treml LS; Cancro MP; Freedman BD
J Biol Chem; 2009 Aug; 284(34):22878-87. PubMed ID: 19542230
[TBL] [Abstract][Full Text] [Related]
5. Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology.
Yu X; Guo C; Fisher PB; Subjeck JR; Wang XY
Adv Cancer Res; 2015; 128():309-64. PubMed ID: 26216637
[TBL] [Abstract][Full Text] [Related]
6. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand.
Calvo J; Places L; Padilla O; Vilà JM; Vives J; Bowen MA; Lozano F
Eur J Immunol; 1999 Jul; 29(7):2119-29. PubMed ID: 10427974
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors
Casadó-Llombart S; Velasco-de Andrés M; Català C; Leyton-Pereira A; Lozano F; Bosch E
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070159
[TBL] [Abstract][Full Text] [Related]
8. SR-B1 Is a Silica Receptor that Mediates Canonical Inflammasome Activation.
Tsugita M; Morimoto N; Tashiro M; Kinoshita K; Nakayama M
Cell Rep; 2017 Jan; 18(5):1298-1311. PubMed ID: 28147282
[TBL] [Abstract][Full Text] [Related]
9. Scavenger receptors in host defense: from functional aspects to mode of action.
Taban Q; Mumtaz PT; Masoodi KZ; Haq E; Ahmad SM
Cell Commun Signal; 2022 Jan; 20(1):2. PubMed ID: 34980167
[TBL] [Abstract][Full Text] [Related]
10. A ligand for CD5 is CD5.
Brown MH; Lacey E
J Immunol; 2010 Nov; 185(10):6068-74. PubMed ID: 20952682
[TBL] [Abstract][Full Text] [Related]
11. The multiple faces of CD5.
Burgueño-Bucio E; Mier-Aguilar CA; Soldevila G
J Leukoc Biol; 2019 May; 105(5):891-904. PubMed ID: 30676652
[TBL] [Abstract][Full Text] [Related]
12. Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.
Zheng Y; Liu Y; Jin H; Pan S; Qian Y; Huang C; Zeng Y; Luo Q; Zeng M; Zhang Z
Theranostics; 2013; 3(7):477-86. PubMed ID: 23843895
[TBL] [Abstract][Full Text] [Related]
13. The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.
Soldevila G; Raman C; Lozano F
Curr Opin Immunol; 2011 Jun; 23(3):310-8. PubMed ID: 21482089
[TBL] [Abstract][Full Text] [Related]
14. Scavenger receptors in human airway epithelial cells: role in response to double-stranded RNA.
Dieudonné A; Torres D; Blanchard S; Taront S; Jeannin P; Delneste Y; Pichavant M; Trottein F; Gosset P
PLoS One; 2012; 7(8):e41952. PubMed ID: 22879901
[TBL] [Abstract][Full Text] [Related]
15. Binding of liposomes composed of phosphatidylcholine to scavenger receptor class B type 1 and its modulation by phosphatidic acid in HEK293T cells.
Koide N; Fujita K; Kuroda S; Hinuma S
Biochim Biophys Acta Mol Cell Res; 2021 Jun; 1868(7):119043. PubMed ID: 33862056
[TBL] [Abstract][Full Text] [Related]
16. CD5 as a Target for Immune-Based Therapies.
Consuegra-Fernández M; Aranda F; Simões I; Orta M; Sarukhan A; Lozano F
Crit Rev Immunol; 2015; 35(2):85-115. PubMed ID: 26351145
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor-specific allergen delivery elicits IFN-gamma-dominated immunity and directs established TH2-dominated responses to a nonallergic phenotype.
Bhatia S; Mukhopadhyay S; Jarman E; Hall G; George A; Basu SK; Rath S; Lamb JR; Bal V
J Allergy Clin Immunol; 2002 Feb; 109(2):321-8. PubMed ID: 11842304
[TBL] [Abstract][Full Text] [Related]
18. The role of scavenger receptors in the innate immune system.
Gough PJ; Gordon S
Microbes Infect; 2000 Mar; 2(3):305-11. PubMed ID: 10758407
[TBL] [Abstract][Full Text] [Related]
19. Identification of scavenger receptor ligands.
Neyen C; Pluddemann A; Gordon S
Methods Mol Biol; 2011; 748():35-50. PubMed ID: 21701965
[TBL] [Abstract][Full Text] [Related]
20. Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx.
Datar R; Kaesemeyer WH; Chandra S; Fulton DJ; Caldwell RW
Br J Pharmacol; 2010 Aug; 160(7):1765-72. PubMed ID: 20649578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]